| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 3e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |